
CHEEK FILLER in Boise, ID
Cheeks Restored to Youthful Face Volume and Fullness with Voluma & Restylane
Spa 35 carries a large variety of dermal fillers for cheeks, temples, under eyes, lips and jawline/chin
Popular fillers include:
Restylane Lyft
Juvederm Voluma
Sculptra
Belatero
Juvederm Ultra
Facial aging is manifested by the loss of volume in the upper face and below the eyes, and an increase in volume in the lower face. Our cheeks are less pronounced, the eyes appear recessed and the nasolabial fold (the parenthesis around the mouth) becomes more pronounced. Our face takes on more of a square shape rather than the youthful inverted triangle.
Dermal fillers, such as Restylane Lyft, Juvederm Voluma and Sculptra can restore facial volume for a more youthful appearance.
Spa 35 typically recommends one syringe of dermal filler per decade of life. So someone in their 50s should plan on 4-6 syringes for maximum results.
Check Out Our Clients’ Cheek Filler Results!
Click images to learn more
Voluma XC from Allergan
VOLUMA® XC was the first injectable gel approved to replace this volume loss in the upper face.
When we're young our "baby face" signals to the world our youth and inexperience. As we age the the collagen in our skin decreases in thickness and the fat in our face shrinks and moves downward.
VOLUMA® XC replaces that loss facial volume, helping to restore your youthful look and minimize the signs of aging, such as hollow eyes and shallow cheeks.
Photographs are used for illustrative and teaching examples only. Results vary by person. Limitations of sun exposure and good diet and exercise habits may positively influence your results.
Face shape changes during the aging process. Cheeks become less prominent and facial volume moves downward. Dermal fillers can help correct these changes.
Treatment plan example - Dermal filler utilization to restore a more youthful appearance of cheeks, nasolabial fold and lips. Photographs are for illustrative purposes only. This is not an actual Spa 35 client.
Voluma FAQs
-
As we age we lose volume in our face from decreased amounts of hyaluronic acid, collagen, and fat. This volume loss can make our faces look shallow and create hollow areas under the eyes. It may also increase the number and impact of skin wrinkles as the same volume of skin is covering a smaller volume of facial structure. Made from a synthetic version of hyaluronic acid, JUVÉDERM VOLUMA® XC replaces the loss volume, and adds volume to areas of the face typically fuller in our youth. Replacing the lost volume can restore a more youthful appearance and improve the appearance of wrinkles.
-
Yes, the FDA has reviewed and approved JUVÉDERM VOLUMA® XC injectable gel for use in the mid-face area. There are warnings for patients that have allergies to lidocaine. The FDA and Allergan have published a lot of documentation on the safety of JUVÉDERM VOLUMA® XC. Allergan has published a fact sheet on JUVÉDERM VOLUMA® XC injectable gel that you can download with this link.
-
The JUVÉDERM VOLUMA® XC material is found under the skin for up to eighteen months. Some patients may want to be treated more frequently to maintain their desired results. Predicting the longevity of JUVÉDERM VOLUMA® XC is dependent upon the individual and their procedure.
How much does VOLUMA® cost?
VOLUMA® XC is sold by the injected syringe. Pricing vary, typical pricing is $800-$2,000, to get current pricing please contact us. When considering Juvederm injections note that an individual procedure may include multiple syringes of VOLUMA® XC. During your consultation the Spa 35 skin specialist can provide a more accurate estimate of the number of syringes recommended to help you reach your goals and the current price per syringe.
What to expect from an JUVÉDERM VOLUMA® XC treatment:
A consultation for new patients.
Depending on individual goals and the condition of your skin, a pre-treatment plan may be recommended to prepare your skin for a JUVÉDERM VOLUMA® XC procedure. This may include a reduction in blood thinning products such as aspirin prior to your treatment.
The JUVÉDERM VOLUMA® XC procedure can take as little as forty-five minutes. There can be discomfort with the injection, this can vary by injection site and patient.
Bruising is always possible with a JUVÉDERM VOLUMA® XC injection, please plan your schedule to accommodate for the possibility of bruising. Usually no downtown is experienced.
Treatments are usually repeated every six to eighteen months.
** Results vary. See Diane's testimonial on her experience with Voluma.
Things to consider when requesting a JUVÉDERM VOLUMA® XC Cosmetic treatment:
JUVÉDERM VOLUMA® XC is made of hyaluronic acid with a patented methodology of production. Hyaluronic acid is naturally produced in your body and it's production slows as we age. Results from JUVÉDERM VOLUMA® XC are seen immediately and can last as long as two years.
During your consultation the Spa 35 staff will review contraindications that prevent you from being a candidate for JUVÉDERM VOLUMA® XC.
Bruising can occur at the injection site. Depending upon your treatment choice a number of injections may be done into the treatment area. Each of these injections has a risk of bruising and infection. Refer to the informed consent form that is provided prior to the treatment for a full listing of risks.
Insights From the Blog
Click images to Read more
Voluma® Important Information from Allergan
VOLUMA® injectable gel is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related
volume deficit in the mid-face in adults over the age of 21.
IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS
VOLUMA® is contraindicated for patients with severe allergies, manifested by a history of anaphylaxis or history or presence of multiple
severe allergies, and a history of allergies to gram-positive bacterial proteins or lidocaine.WARNINGS
VOLUMA® injectable gel must not be injected into blood vessels and should not be used in vascular-rich areas. Use in these areas, such
as glabella and nose, has resulted in cases of vascular embolization, occlusion of the vessels, ischemia or infarction, or blindness. Symptoms of vessel
occlusion and embolization include pain that is disproportionate to the procedure or remote to the injection site, immediate blanching extending beyond the injected area, and color changes that reflect ischemic tissue such as a dusky or reticular appearanceProduct use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should
be deferred until the underlying process has been controlledPRECAUTIONS
The safety and effectiveness for the treatment of anatomic regions other than the mid-face have not been established
As with all transcutaneous procedures, dermal filler implantation carries a risk of infection. Follow standard precautions associated with injectable materials
The safety for use during pregnancy, in breastfeeding females, and in patients with very thin skin in the mid-face region has not been established
The safety for use in patients under 35 years or over 65 years has not been established
The safety in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied
VOLUMA® injectable gel should be used with caution in patients on immunosuppressive therapyPatients who are using products that can prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites
Patients who experience skin injury near the site of VOLUMA® implantation may be at a higher risk for adverse events
Patients may experience late onset nodules with use of dermal fillers including VOLUMA®
Patients should be limited to 20 mL of VOLUMA® per 60 kg (130 lbs) body mass per year. The safety of injecting greater amounts has
not been establishedVOLUMA® should only be used by physicians who have appropriate experience and who are knowledgeable about facial anatomy and the
product for use in deep (subcutaneous and/or supraperiosteal) injection for cheek augmentationADVERSE EVENTS
Side effects in > 5% of subjects were temporary injection-site tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and
itching. They were predominantly moderate in severity, with a duration of 2 to 4 weeks.To report an adverse reaction, please call Allergan Product Surveillance at 1-877-345-5372.
For more information, please see the About Safety page at www.juvederm.com or call the Allergan Medical Information line
at 1-800-433-8871.VOLUMA® injectable gel is available by prescription only.
